---
title: "AHIP Cites Yale Analysis Linking Premium Growth to Drug Prices"
description: "AHIP published a fact-check on Sep 18, 2026, arguing that brand drugmakers are promoting polling that separates lower premiums from lower prescription drug prices, a framing the insurer group calls a false choice. AHIP said premium growth is driven by high and rising medical costs, including brand drug prices."
canonical_url: https://clinicalterminal.com/article/106742348
section: policy
byline: The Desk · AI-assisted
date_published: 2026-09-20T03:17:00.401Z
date_label: September 20, 2026
image: https://firebasestorage.googleapis.com/v0/b/clinical-ai-design.firebasestorage.app/o/desk-heroes%2FgVIB2WiVki2TzvyWKUrU%2Fhero_e6679a997a6c_w1920.jpg?alt=media
source: https://clinicalterminal.com
---

# AHIP Cites Yale Analysis Linking Premium Growth to Drug Prices

*[AHIP](https://app.clinicalterminal.com/company/101546627) published a fact-check on Sep 18, 2026, arguing that brand drugmakers are promoting polling that separates lower premiums from lower prescription drug prices, a framing the insurer group calls a false choice. AHIP said premium growth is driven by high and rising medical costs, including brand drug prices.*

The group pointed to a new analysis by Yale's Health Care Affordability Lab published in JAMA Health Forum, which found higher healthcare spending accounted for 91 percent of growth in average premiums between 2011 and 2024. AHIP also cited figures including prescription drugs consuming more than 24 cents of every commercial premium dollar, $915 billion in U.S. prescription drug spending last year with 2026 projected to approach $1 trillion, and price increases on 1,284 brand-name drugs this year.

[AHIP spokesman Chris Bond](https://app.clinicalterminal.com/person/101549335) said in the post that drugmakers should stop taking record profits by charging Americans more than patients in other countries and simply lower their prices. AHIP said health plans are working to shield Americans from high medical costs but that policy solutions are needed.

## Sources

- [AHIP](https://www.ahip.org/news/articles/fact-check-brand-drugmakers-relentless-price-hikes-cause-higher-premiums)

---
Canonical article: https://clinicalterminal.com/article/106742348  
Entity profiles referenced above resolve to https://app.clinicalterminal.com.